Sun Pharmaceutical Industries Limited
Listed as SUNPHARMA: its shares held by funds are on the stock page.
| Scheme | Held | % of scheme | Sep 2026 |
|---|---|---|---|
| SBI Aggressive Hybrid Fund SBI Mutual Fund | ₹1,150 cr | 1.33% | — |
| ADITYA BIRLA SUN LIFE CORPORATE BOND FUND Aditya Birla Sun Life Mutual Fund | ₹100 cr | 0.42% | — |
| SBI Balanced Hybrid Fund SBI Mutual Fund | ₹50.0 cr | 2.49% | — |
| Kotak Aggressive Hybrid Fund Kotak Mahindra Mutual Fund | ₹25.0 cr | 0.28% | — |
| Nippon India Balanced Advantage Fund Nippon India Mutual Fund | ₹25.0 cr | 0.26% | — |
| Nippon India Multi Asset Allocation Fund Nippon India Mutual Fund | ₹25.0 cr | 0.14% | — |
% of scheme: the share of the scheme's net assets, as the fund house states it. Sep 2026: "—" = no Sep 2026 portfolio from that fund house.
| Security | Grade or sector, as printed | Held | Schemes |
|---|---|---|---|
| 8.05% Sun Pharmaceutical Industries Limited** Bond / debenture · INE044A08023 | CRISIL AAA | ₹774 cr | 4 |
| Sun Pharmaceutical Industries Ltd. Bond / debenture · INE044A08015 | CRISIL AAA | ₹600 cr | 3 |
Name, and the credit agency grade (or a sector, where the fund house prints one), as the fund houses print them: several spellings, the most common; several grades, all of them, most common first. This site gives no view on credit.
| Month | Held | Schemes | Fund houses holding / covered |
|---|---|---|---|
| Oct 2026 | ₹1,375 cr | 6 | 4 / 38 |
A month with fewer fund houses covered is not comparable in full with one with more. Bonds, debentures, commercial paper, certificates of deposit, securitised debt and preference shares a company, bank or trust issued, as each fund house lists them in its monthly portfolio. Government securities, REIT/InvIT units and fund units are not included. Credit agency grades are copied as the fund house prints them; this site gives no view on credit. Not investment advice.